PubRank

Andrew F Leuchter

Author PubWeight™ 42.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evid Based Complement Alternat Med 2007 2.22
2 Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychol Methods 2011 1.49
3 Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry 2004 1.42
4 Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res 2009 1.09
5 A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome. J Clin Psychiatry 2015 1.07
6 Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002 1.06
7 Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res 2005 1.05
8 Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry 2004 1.04
9 Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol 2004 1.03
10 Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav 2013 1.02
11 Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Arch Neurol 2002 0.98
12 Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry 2006 0.96
13 Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatr Serv 2005 0.93
14 Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res 2009 0.92
15 Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol 2003 0.92
16 A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res 2013 0.90
17 Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety 2013 0.90
18 Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr 2008 0.89
19 Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol 2009 0.89
20 Does the clinical course of depression determine improvement in symptoms and quality of life? J Nerv Ment Dis 2006 0.89
21 Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry 2005 0.87
22 The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatr Clin North Am 2007 0.86
23 Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics 2005 0.85
24 Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. J Clin Psychopharmacol 2010 0.85
25 Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav 2013 0.85
26 Aging and brain activation with working memory tasks: an fMRI study of connectivity. Int J Geriatr Psychiatry 2007 0.84
27 Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res 2011 0.82
28 Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology (Berl) 2015 0.81
29 Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci 2009 0.80
30 Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurg Clin N Am 2014 0.80
31 Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology 2005 0.80
32 Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? J Neuropsychiatry Clin Neurosci 2013 0.79
33 Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry 2002 0.79
34 Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology 2014 0.79
35 Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. J Clin Psychopharmacol 2010 0.79
36 Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas 2006 0.79
37 Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry 2013 0.79
38 The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. J Clin Neurophysiol 2011 0.78
39 Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology 2005 0.77
40 Predictors of improved mood over time in clinical trials for major depression. Psychiatry Res 2004 0.77
41 Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Med 2009 0.76
42 Effects of heart disease on depression treatment: results from the COMED study. Gen Hosp Psychiatry 2011 0.76
43 Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clin EEG Neurosci 2010 0.76
44 Does prior antidepressant treatment of major depression impact brain function during current treatment? Eur Neuropsychopharmacol 2012 0.76
45 Pretreatment neurophysiologic function and ECT response in depression. J ECT 2004 0.76
46 Insured and non-insured depressed outpatients: how do they compare? Ann Clin Psychiatry 2007 0.75
47 Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Med Hypotheses 2013 0.75